Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentöse Tumortherapie
暂无分享,去创建一个
R. Greil | M. Fridrik | M. Raderer | A. Zebisch | W. Willenbacher | M. Troch | W. Linkesch | B. Kiesewetter | L. Müllauer | E. Willenbacher